Reference intervals for aCL and anti-β2GPI IgAGM antibodies in a large health-inspection population: a foundational study for combined-isotype assay interpretation. [PDF]
Lupus Sci MedSun G +7 more
europepmc +1 more source
VEXAS Mimicking Antiphospholipid Syndrome: Diagnostic Challenges of False-Positive Antiphospholipid Antibodies. [PDF]
Int J Mol SciKhan S, Eiman H, Nusrat S.
europepmc +1 more source
Hemophagocytic Lymphohistiocytosis Thought to Be due to Undifferentiated Connective Tissue Disease Treated With Ruxolitinib: A Case Report. [PDF]
Case Rep RheumatolVachon E, Jain HB, Kitten S.
europepmc +1 more source
Perioperative Use of Efgartigimod Alfa, a Neonatal Fc Receptor Antagonist, to Reduce Antiphospholipid Antibody Titers and Thrombotic Risk in a Kidney Transplant Recipient. [PDF]
Kidney MedAchkar K +7 more
europepmc +1 more source
Avidity of Anti-β2-Glycoprotein I Antibodies in Patients With Antiphospholipid Syndrome
Lupus, 2012 Antibodies against β2-glycoprotein I (anti-β2GPI) are one of the hallmarks of the antiphospholipid syndrome (APS). However, they are heterogenic regarding their epitope specificity, pathogenic mechanisms and their avidity. In the current study we present
Guido Valesini, S Cucnik, T Iwaniec
exaly +2 more sources
Inter-Laboratory Variability of Anti-β2-Glycoprotein I Measurement
Thrombosis and Haemostasis, 2002 SummaryInter-laboratory variability of anti-β2-glycoprotein I antibody measurements (IgG and IgM) was investigated in the frame of the European Forum on Antiphospholipid Antibodies and its Standardization Group.
Angela Tincani +2 more
exaly +2 more sources
Related searches:
Anti-Beta 2 Glycoprotein I IgA in the SLICC Classification Criteria Dataset
Lupus, 2021Graciela Alarcon +2 more
exaly
β2-Glycoprotein I–Anti-β2-Glycoprotein I Interaction
Journal of Autoimmunity, 2000Tatsuya Atsumi +2 more
exaly